Longitudinal study of amnesic patients at high risk for Alzheimer's disease: Clinical, neuropsychological and magnetic resonance spectroscopy features

Dementia and Geriatric Cognitive Disorders

Volumn 24, Issue 5, 2007, Pages 402-410

  Rami, Lorena ^a   Gómez Anson, Beatriz ^b,c   Sanchez Valle, Raquel ^a   Bosch, Beatriz ^a   Monte, Gemma C ^b,c   Lladó, Albert ^a   Molinuevo, José L ^a,b,c  

^a Institute of Neurosciences INc   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

Alzheimer's disease; Mild cognitive impairment; Neuropsychology; Prodromal AD; Spectroscopy

Indexed keywords

AGED; ALZHEIMER DISEASE; AMNESIA; ARTICLE; BRAIN FUNCTION; CLINICAL FEATURE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE SEVERITY; EPISODIC MEMORY; FEMALE; FOLLOW UP; FRONTAL LOBE; HIGH RISK PATIENT; HUMAN; LANGUAGE ABILITY; LOGISTIC REGRESSION ANALYSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PERCEPTION; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTON NUCLEAR MAGNETIC RESONANCE; SCORING SYSTEM; VISUAL MEMORY;

AGED; ALZHEIMER DISEASE; AMNESIA; CASE-CONTROL STUDIES; COGNITION DISORDERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES; REFERENCE VALUES; RISK FACTORS;

EID: 35648966134     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000109750     Document Type: Article

References (41)

1. Petersen RC, Doody R, Kurz A, et al: Current concepts in mild cognitive impairment. Arch Neurol 2001;58:1985-1992.
2. Burns A, Zaudig M: Mild cognitive impairment in older people. Lancet 2002;360:1963-1965.
3. Ritchie K, Artero S, Touchon J: Classification criteria for mild cognitive impairment: a population-based validation study. Neurology 2001;56:37-42.
4. Fischer P, Jungwirth S, Zehetmayer S, Weissgram S, Hoenigschnabl S, Gelpi E, Krampla W, Tragl KH: Conversion from subtypes of mild cognitive impairment. Neurology 2007;23:288-291.
5. Ritchie K: Mild cognitive impairment: an epidemiological perspective. Dialogues Clin Neurosci 2004;6:401-408.
6. Tierney MC, Szalai JP, Snow WG, Fisher RH: The prediction of Alzheimer disease: the role of patient and informant perceptions of cognitive deficits. Arch Neurol 1996;53:423-427.
7. Peres K, Chrysostome V, Fabrigoule C, Orgogozo JM, Dartigues JF, Barberger-Gateau P: Restriction in complex activities of daily living in MCI: impact on outcome. Neurology 2006;67:461-466.
8. Bozoki A, Giordani B, Heidebrink J, Berent S, Foster N: Mild cognitive impairments predict dementia in nondemented elderly patients with memory loss. Arch Neurol 2001;58:411-416.
9. Valenzuela M, Sachdev P: Magnetic resonance spectroscopy in AD. Neurology 2001;56:592-598.
10. Modrego PJ, Fayed N, Pina MA: Conversion from mild cognitive impairment to probable Alzheimer's disease predicted by brain magnetic resonance spectroscopy. Am J Psychiatry 2005;162:645-647.
11. Kantarci K, Jack CR, Xu YC, Campeau NG, O'Brien PC, Smith GE, Ivnik RJ, Boeve BF, Kokmen E, Tangalos EG, Petersen RC: Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: a 1H MRS study. Neurology 2000;55:210-217.
12. Ackl N, Ising M, Schreiber YA, Atiya M, Sonntag A, Auer DP: Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease. Neurosci Lett 2005;384:23-28.
13. Lopez OL, Jagust WJ, Dekosky ST, Becker JT, Fitzpatrick A, Dulberg C, Breitner J, Lyketsos C, Jones B, Kawas C, Calson M, Kuller LH: Prevalence and classification of mild cognitive impairment in the cardiovascular health study cognition study. Arch Neurol 2003;60:1385-1389.
14. Pena-Casanova J, Guardia J, Bertran-Serra I, Manero RM, Jarne A: Shortened version of the Barcelona test (I): subtests and normal profiles. Neurologia 1997;12:99-111.
15. Visser PJ, Scheltens P, Verhey FRJ: Do MCI criteria in drug trials accurately identify subjects with predementia Alzheimer's disease? J Neurol Neursurg Psychiatry 2005;76:1348-1354.
16. Folstein MF, Folstein SE, McHugh PR: 'Minimental state': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
17. Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, Mellits ED, Clark C: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989;39:1159-1165.
18. Garcia-Albea JE, Sanchez-Bernardos ML, del Viso-Pabon S: Test de Boston para el diagnóstico de la afasia: adaptación española; in Goodglass H, Kaplan E: La evaluación de la afasia y de trastornos relacionados, ed 2 (translated by C Wernicke). Madrid, Editorial Medica Panamericana, 1986, pp 129-198.
19. Golden CJ, Hammeke TA, Purisch AD: The Luria-Nebraska Neuropsychological Battery. Los Angeles, Western Psychological Services, 1980.
20. Rami L, Serradell M, Bosch B, Villar A, Molinuevo JL: Test digital de percepción (TDP) para la valoración de trastornos perceptivos incipientes en la enfermedad de Alzheimer inicial. Neurología 2007;22:342-347-.
21. Borkowski JG, Benton AL, Spreen O: Word fluency and brain damage. Neuropsychologia 1967;5:135-140.
22. Reitan RM: Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills 1958;8:271-276.
23. Wechsler D: Escala de inteligencia de Wechsler para adultos-III (WAIS III). Madrid, TEA, 1999.
24. Rami L, Serradell M, Bosch B, Caprile C, Sekler A, Villar A, Canal R, Molinuevo JL: Semantic memory tests in the Spanish elderly: normative data for the Boston Naming Test and for the Pyramids and Palm Trees Test. J Clin Exp Neuropsychol, in press.
25. Pfeffer RI, Kurosaki TT, Harrah CH, Chance JM, Filos S: Measurement of functional activities in older adults in the community. J Gerontol 1982;37:323-329.
26. Tabert MH, Albert SM, Borukhova-Milov L, Camacho Y, Pelton G, Liu X, Stern Y, Devanand DP: Functional deficits in patients with mild cognitive impairment: prediction of AD. Neurology 2002;58:758-764.
27. Blesa R, Adroer R, Santacruz P, Ascaso C, Tolosa E, Oliva R: High apolipoprotein E ε4 allele frequency in age-related memory decline. Ann Neurol 1996;39:515-518.
28. Provencher SW: Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993;30:672.
29. Gómez-Ansón B, Alegret M, Muñoz E, Sainz A, Monte GC, Tolosa E: Decreased frontal choline and neuropsychological performance in preclinical Huntington's disease. Neurology 2007;68:906-910.
30. Restuccia T, Gómez-Ansón B, Guevara M, Alessandria C, Torre A, Alayrach ME, Terra C, Martín M, Castellví M, Rami L, Sainz A, Ginès P, Arroyo V: Effects of dilutional hyponatremia on brain organic osmolytes and water content in patients with cirrhosis: a magnetic resonance study. Hepatology 2004;39:1613-1622.
31. Dubois B: 'Prodromal Alzheimer's disease': a more useful concept than mild cognitive impairment? Curr Opin Neurol 2000;13:367-369.
32. Dubois B, Albert ML: Amnesic MCI or prodromal Alzheimer's disease? Lancet Neurol 2004;3:246-248.
33. Drzezga A, Lautenschlager N, Siebner H, Riemenschneider M, Willoch F, Minoshima S, Schwaiger M, Kurz A: Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study. Eur J Nucl Med Mol Imaging 2003;30:1104-1113.
34. Kantarci K, Smith GE, Petersen RC, Boeve BF, Knopman DS, Tangalos EG, Jack CR: 1H magnetic resonance spectroscopy, cognitive function, and apolipoprotein E genotype in normal aging, mild cognitive impairment and Alzheimer's disease. J Int Neuropsychol Soc 2002;8:934-942.
35. Killiany RJ, Gomez-Isla T, Moss M, Kikinis R, Sandor T, Jolesz F, Tanzi R, Jones K, Hyman BT, Albert MS: Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease. Ann Neurol 2000;47:430-439.
36. Griffith HR, Belue K, Sicola A, Krzywanski S, Zamrini E, Harrell L, Marson DC: Impaired financial abilities in mild cognitive impairment: a direct assessment approach. Neurology 2003;60:449-457.
37. Lopez OL, Becker JT, Jagust WJ, Fitzpatrick A, Carlson MC, DeKosky ST, Breitner J, Lyketsos CG, Jones B, Kawas C, Kuller LH: Neuropsychological characteristics of mild cognitive impairment subgroups. J Neurol Neurosurg Psychiatry 2006;77:159-165.
38. Portet F, Ousset PJ, Visser PJ, Frisoni GB, Nobili F, Scheltens P, Vellas B, Touchon J: Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure - Report of the MCI Working Group of the European Consortium on Alzheimer's Disease. J Neurol Neurosurg Psychiatry 2006;77:714-718.
39. Elias MF, Beiser A, Wolf PA, Au R, White RF, D'Agostino RB: The preclinical phase of Alzheimer disease: a 22-year prospective study of the Framingham Cohort. Arch Neurol 2000;57:808-813.
40. Daly E, Zaitchik D, Copeland M, Schmahmann J, Gunther J, Albert M: Predicting conversion to Alzheimer disease using standardized clinical information. Arch Neurol 2000;57:675-680.
41. Chen P, Ratcliff G, Belle SH, Cauley JA, Dekosky ST, Ganguli M: Cognitive tests which best discriminate between presymptomatic AD and those who remain non-demented. Neurology 2000;55:1847-1853.